Every SEC Form 3/4/5 on record for this filer (CIK 1676880) — 5 issuers, 19 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Director | 2024-06-11 → 2026-06-26 | 4 | — |
| GBIO | Generation Bio Co. | Director | 2021-03-03 → 2026-02-09 | 8 | — |
| ENGN | enGene Therapeutics Inc. | CEO & President · Director | 2024-07-24 → 2026-02-03 | 5 | $57,000 |
| ALBO | ALBIREO PHARMA, INC. | President and CEO · Director · lapsed | 2016-11-07 → 2023-03-02 | 21 | −$176,123 |
| GNCA | GENOCEA BIOSCIENCES, INC. | Director · lapsed | 2016-06-10 → 2020-06-19 | 6 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ENGN | 2024-09-27 | Buy | 10,000 | $5.70 | $57,000 | 10,000 |
| ALBO | 2023-01-23 | Sell | 1,057 | $43.80 | $46,297 | 57,444 |
| ALBO | 2022-10-24 | Sell | 919 | $19.58 | $17,994 | 55,461 |
| ALBO | 2022-10-24 | Sell | 919 | $19.58 | $17,994 | 58,501 |
| ALBO | 2022-07-22 | Sell | 929 | $24.67 | $22,918 | 56,380 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.
